Diseases of blood system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patient signs an informed consent form, voluntarily joins this study, and has the willingness and ability to cooperate with data collection in this study; 2. Clinical diagnosis are hematological disorders; 3. Intending to receive or have received treatment with injectable cetriptyline (whether to prescribe injectable cetriptyline is determined by the supervising physician and is not affected by this study).
Exclusion criteria
Exclusion criteria: 1. The patient is undergoing clinical intervention research; 2. Unable to understand the nature of the research or without obtaining informed consent; 3. Researchers determine other situations that are not suitable for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival;progression-free survival;recurrence rate; | — |
Countries
China
Contacts
Guangdong Provincial Hosipital of Chinese Medicine